Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Dominant CHCHD10 variants have been identified in familial and sporadic amyotrophic lateral sclerosis (ALS) patients. Autosomal dominant inheritance has been observed with segregating p.Ser59Leu in a large kindred manifesting motor neuron degeneration and frontotemporal dementia (3 affected) (PMID:25155093). Additional rare missense and nonsense variants (p.Pro34Ser, p.Ala35Asp, p.Arg15Leu, p.Gly66Val) have been reported in ~10 unrelated ALS probands across European and Asian cohorts (≤1% frequency) (PMID:25726362, PMID:27056076, PMID:28069311, PMID:28318595). A large burden study found no enrichment of CHCHD10 missense variants in 4,365 ALS versus 1,832 controls (PMID:30014597).
Robust functional data support a dominant gain-of-function mechanism. p.Ser59Leu knock-in mice develop mitochondrial cardiomyopathy and neuromuscular junction degeneration with motor neuron loss (PMID:30874923), and p.Pro80Leu zebrafish display motor impairment and NMJ defects (PMID:39260590). CHCHD10 Q108P disrupts Mia40-mediated mitochondrial import (PMID:29789341), and loss-of-function mutations induce cytoplasmic TDP-43 aggregates and synaptic damage (PMID:28585542). CHCHD10 mutants also impair PARL-PINK1–dependent mitophagy, promoting TDP-43 pathology (PMID:38132101). Together, genetic and experimental evidence support a role for CHCHD10 variants in ALS, although rare frequency and lack of burden enrichment temper diagnostic sensitivity.
Key take-home: CHCHD10 should be considered in dominant ALS, especially with early mitochondrial dysfunction or FTD features.
Gene–Disease AssociationLimited~10 probands total with rare variants, single-family segregation, burden test negative Genetic EvidenceLimited≤10 case-level reports with minimal segregation (3 relatives) Functional EvidenceModerateMultiple in vivo models (mouse, zebrafish) and cellular assays demonstrating pathogenic mechanisms |